UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Annals of the rheumatic diseases, 2004-05, Vol.63 (5), p.508-516

2004

Volltextzugriff (PDF)

Leukocyte chemotactic activity of cyclophilin

The Journal of biological chemistry, 1992-06, Vol.267 (17), p.11968-11971

1992

Volltextzugriff (PDF)

741P Phase I results demonstrate highly differentiated safety and PK profile of ADG126, a masked anti-CTLA-4 SAFEbody in patients with advanced solid tumors

Annals of oncology, 2022-09, Vol.33, p.S882-S883

2022

Volltextzugriff (PDF)

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

Intensive care medicine, 2001-07, Vol.27 (7), p.1169-1178

2001

Volltextzugriff (PDF)

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

Annals of oncology, 2021-12, Vol.32, p.S1436-S1437

2021

Volltextzugriff (PDF)

Stem Cells as an Emerging Paradigm in Stroke 3: Enhancing the Development of Clinical Trials

Stroke (1970), 2014-02, Vol.45 (2), p.634-639

2014

Volltextzugriff (PDF)

Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II

Stroke, 2011-03, Vol.42 (3), p.825-829

2011

Volltextzugriff (PDF)

Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies

Stroke (1970), 2011-09, Vol.42 (9), p.2645-2650

2011

Volltextzugriff (PDF)

Factors associated with recurrent appendicitis after successful treatment with antibiotics

British journal of surgery, 2023-10, Vol.110 (11), p.1482-1489

Flum, David R

2023

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2770-2779

1998

Volltextzugriff (PDF)

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)

Journal of rheumatology, 2003-12, Vol.30 (12), p.2563

2003

Volltextzugriff (PDF)

Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60

The Journal of experimental medicine, 1984-07, Vol.160 (1), p.179-196

1984

Volltextzugriff (PDF)

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial

Arthritis and rheumatism, 2004-05, Vol.50 (5), p.1400-1411

2004

Volltextzugriff (PDF)

Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid

Cancer research (Chicago, Ill.), 1989-07, Vol.49 (13), p.3594-3597

1989

Volltextzugriff (PDF)

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study

Clinical therapeutics, 2003-06, Vol.25 (6), p.1700-1721

2003

Volltextzugriff (PDF)

Glucocorticoid and progestin regulation of eosinophil chemotactic factor and complement C3 in the estrogen-treated rat uterus

Endocrinology (Philadelphia), 1990-06, Vol.126 (6), p.3193-3199

1990

Volltextzugriff (PDF)

Acute eosinophilic leukemia with a (10; 11) chromosomal translocation

Leukemia, 1988-06, Vol.2 (6), p.394-397

1988

Volltextzugriff (PDF)

Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions

Cancer research (Chicago, Ill.), 1985-05, Vol.45 (5), p.2065-2069

1985

Volltextzugriff (PDF)

Response to "More is not always better: a case for low-dose leucovorin"

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1434-1435

1993

Volltextzugriff (PDF)

Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions

Leukemia research, 1988, Vol.12 (8), p.679-686

Fischkoff, Steven A.

1988

Volltextzugriff (PDF)

Lineage directed HL-60 cell sublines as a model system for the study of early events in lineage determination of myeloid cells

Leukemia research, 1990, Vol.14 (11), p.979-988

1990

Volltextzugriff (PDF)

Synthesis of Eosinophil-Associated Enzymes in HL-60 Promyelocytic Leukemia Cells

Blood, 1986-07, Vol.68 (1), p.185-192

1986

Volltextzugriff (PDF)

Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid

Leukemia, 1990-04, Vol.4 (4), p.302-306

1990

Volltextzugriff (PDF)

Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multi-peptide vaccine for resected stages IIIC and IV melanoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2510-2510

2006

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(93)
Buchkapitel
(1)

Sprache

Englisch
(94)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Humans
(54)
Biological And Medical Sciences
(26)
Female
(19)
Male
(17)
Medical Sciences
(16)
Adult
(15)
Middle Aged
(15)
Surgery
(14)
Oncology
(13)
Treatment Outcome
(13)
Aged
(12)
Fundamental And Applied Biological Sciences. Psychology
(10)
General & Internal Medicine
(9)
Cell Line
(8)
Cell Physiology
(8)
Hematology
(8)
Molecular And Cellular Biology
(8)
Butyric Acid
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Leukocyte chemotactic activity of cyclophilin

741P Phase I results demonstrate highly differentiated safety and PK profile of ADG126, a masked anti-CTLA-4 SAFEbody in patients with advanced solid tumors

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

Stem Cells as an Emerging Paradigm in Stroke 3: Enhancing the Development of Clinical Trials

Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II

Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies

Factors associated with recurrent appendicitis after successful treatment with antibiotics

A Video-Based Consent Tool: Development and Effect of Risk–Benefit Framing on Intention to Randomize

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)

Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial

Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study

Glucocorticoid and progestin regulation of eosinophil chemotactic factor and complement C3 in the estrogen-treated rat uterus

Acute eosinophilic leukemia with a (10; 11) chromosomal translocation

Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions

Response to "More is not always better: a case for low-dose leucovorin"

Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions

Lineage directed HL-60 cell sublines as a model system for the study of early events in lineage determination of myeloid cells

Synthesis of Eosinophil-Associated Enzymes in HL-60 Promyelocytic Leukemia Cells

Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid

Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multi-peptide vaccine for resected stages IIIC and IV melanoma

Suchergebnisse filtern